#COVID19 #Coronavirus
Vaccination, Clinical trial, Vaccine, Immunology, Immune system, Smallpox

Coronavirus tracker: United Airlines to offer Abbott's test on certain routes; vaccine safety pledge buoys pharma's rep

On Sep 25, 2020
@PeterDiamandis shared
RT @COVAXX_: Stay up to date on COVAXX's latest #COVID19 vaccine candidate news with Fierce Pharma #Coronavirus Tracker. See the tracker here: https://t.co/wKI4BbSyVL
Open

United Airlines will start screening passengers on certain routes with Abbott's rapid swab test for COVID-19. Americans aware of a recent vaccine safety pledge by nine drugmakers had a more positive view of those companies, a new Harris Poll found. ...

www.fiercepharma.com
On Sep 25, 2020
@PeterDiamandis shared
RT @COVAXX_: Stay up to date on COVAXX's latest #COVID19 vaccine candidate news with Fierce Pharma #Coronavirus Tracker. See the tracker here: https://t.co/wKI4BbSyVL
Open

Coronavirus tracker: United Airlines to offer Abbott's test on certain routes; vaccine safety pledge buoys pharma's rep

Coronavirus tracker: United Airlines to offer Abbott's test on certain routes; vaccine safety pledge buoys pharma's rep

United Airlines will start screening passengers on certain routes with Abbott's rapid swab test for COVID-19. Americans aware of a recent vaccine safety pledge by nine drugmakers had a more ...

Biopharma Update on the Novel Coronavirus: April 9

Biopharma Update on the Novel Coronavirus: April 9

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.

Russia seals another deal to supply and test its coronavirus vaccine abroad

Russia seals another deal to supply and test its coronavirus vaccine abroad

Russia's sovereign wealth fund will supply 100 million doses of its potential coronavirus vaccine to Indian drug company Dr Reddy's Laboratories, the fund said on Wednesday, as Moscow ...

Beyond the noise, biopharma battles on with science for COVID-19

Beyond the noise, biopharma battles on with science for COVID-19

As 2020 approaches its last quarter, scientists around the globe continue their all-consuming efforts to find effective therapeutics and vaccines to fight the deadly COVID-19 pandemic, ...

What we know -- and don't know -- about Russia's 'Sputnik V' vaccine

What we know -- and don't know -- about Russia's 'Sputnik V' vaccine

Russia raised eyebrows on Tuesday when it announced the world's first approved coronavirus vaccine for public use.

How to Conquer Coronavirus: Top 35 Treatments in Development

How to Conquer Coronavirus: Top 35 Treatments in Development

A new survey by Genetic Engineering & Biotechnology News (GEN) reveals 35 active drug development programs in North America, Europe and China.

An updated guide to the coronavirus drugs and vaccines in development

An updated guide to the coronavirus drugs and vaccines in development

Here’s a guide to some of the most talked-about efforts to treat or prevent coronavirus infection, with details on the science and timeline for each. 

Coronavirus testing: the global race to find a rapid test which can produce on-the-spot results

Coronavirus testing: the global race to find a rapid test which can produce on-the-spot results

Researchers are racing to develop a 'game-changing' Covid-19 test that can produce a result in 10 to 15 minutes

Two Pharma Companies Released Their Coronavirus Vaccine Blueprints In A Bid To Regain Public Trust

Two Pharma Companies Released Their Coronavirus Vaccine Blueprints In A Bid To Regain Public Trust

The disclosures from the two frontrunners, Pfizer and Moderna, come as public trust in a coronavirus vaccine is declining.

White House pressure for a vaccine raises risk the U.S. will approve one that doesn’t work

White House pressure for a vaccine raises risk the U.S. will approve one that doesn’t work

Drugmakers and health agencies have already begun rewriting the rules of vaccine research.

COVID-19 vaccine development reported in various countries

COVID-19 vaccine development reported in various countries

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co., Ltd. (Sinopharm) in Beijing, capital of China, ...

UPDATED Coronavirus tracker: We're at a 'decisive point,' WHO chief says; Japan closing schools

UPDATED Coronavirus tracker: We're at a 'decisive point,' WHO chief says; Japan closing schools

President Donald Trump has selected Vice President Mike Pence to lead the U.S. coronavirus response. Meanwhile, U.S. authorities reported the first COVID-19 case from an unknown origin in ...

Here are the drugs, vaccines and therapies in development to tackle COVID-19

Here are the drugs, vaccines and therapies in development to tackle COVID-19

Currently, there are over 70 vaccine candidates in development around the world. Here are 20 of the most promising drugs, therapies and vaccines.

What coronavirus treatment and vaccine candidates are showing promising results?

What coronavirus treatment and vaccine candidates are showing promising results?

Since the beginning of the Covid-19 outbreak scientists have been trying to find drugs to fight the virus, and vaccines to protect people.

Russia Is Slow to Administer Virus Vaccine Despite Kremlin’s Approval

Russia Is Slow to Administer Virus Vaccine Despite Kremlin’s Approval

After announcing the first government clearance for a coronavirus vaccine, Russia delayed distributing it. It remains unclear how many people have received it.

Getting a Covid-19 vaccine — quickly and safely

Getting a Covid-19 vaccine — quickly and safely

Researchers around the globe are working with unprecedented speed to find the vaccines we need to find our way through the pandemic. What’s the bar for safety and effectiveness?

Every Vaccine and Treatment in Development for COVID-19, So Far

Every Vaccine and Treatment in Development for COVID-19, So Far

As the number of confirmed COVID-19 cases continues to skyrocket, healthcare researchers around the world are working to defeat the virus.

FDA may be risk-averse to grant emergency use for a Covid-19 vaccine; political pressure and hazy EUA standards are factors

FDA may be risk-averse to grant emergency use for a Covid-19 vaccine; political pressure and hazy EUA standards are factors

The FDA’s revocation of chloroquine and hydroxychloroquine’s EUA after three months could mean the FDA may raise the bar for Covid-19 vaccines

Covid-19 roundup: Albert Bourla says Pfizer PhIII is at 23,000 patients, submission coming end of October

Covid-19 roundup: Albert Bourla says Pfizer PhIII is at 23,000 patients, submission coming end of October

Months ago, public health officials thought it could take several months to prove a vaccine works. Even when continually high coronavirus case counts in the US made trials easier to run, ...

Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer

Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer

Regeneron has moved forward its time frame for having doses of a potential coronavirus vaccine and treatment ready for human testing.

Dozens of COVID-19 vaccines are in development. Here are the ones to follow.

Dozens of COVID-19 vaccines are in development. Here are the ones to follow.

Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.